Can you provide the last earnings date for FATE THERAPEUTICS INC?
FATE THERAPEUTICS INC (FATE) last reported earnings on 2/26/2026.
FATE THERAPEUTICS INC (FATE) Earnings History & Surprises
NASDAQ:FATE • US31189P1021
Current stock price
1.24 USD
+0.04 (+3.33%)
At close:
1.24 USD
0 (0%)
After Hours:
FATE Earnings overview
Past quarterly earnings results for FATE THERAPEUTICS INC (FATE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.29
- Revenue Estimate
- 1.082M
Last Reported
Most Recent- Release Date
- Feb 26, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.27
- EPS Surprise
- 1.85%
- Revenue Surprise
- 1.86%
Beat Rate
Last 8 Quarters 100%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.27 | -0.28 | 1.85% | 38.64% | 1.369M | 1.344M | 1.86% | -26.40% |
| Q3 2025 | -0.27 | -0.30 | 9.06% | 32.50% | 1.741M | 1.566M | 11.17% | -43.36% |
| Q2 2025 | -0.29 | -0.35 | 16.98% | 12.12% | 1.907M | 1.031M | 84.97% | -71.84% |
| Q1 2025 | -0.32 | -0.39 | 18.09% | 31.91% | 1.629M | 1.165M | 39.83% | -15.38% |
| Q4 2024 | -0.44 | -0.44 | 0.25% | 2.22% | 1.86M | 1.444M | 28.81% | 10.98% |
| Q3 2024 | -0.40 | -0.44 | 9.28% | 13.04% | 3.074M | 1.352M | 127.37% | 58.13% |
| Q2 2024 | -0.33 | -0.48 | 31.92% | 38.89% | 6.772M | 1.437M | 371.26% | 625.83% |
| Q1 2024 | -0.47 | -0.50 | 5.72% | -147.37% | 1.925M | 1.137M | 69.31% | -96.74% |
| Q4 2023 | -0.45 | -0.53 | 15.58% | 22.41% | 1.676M | 1.626M | 3.08% | -96.22% |
| Q3 2023 | -0.46 | -0.58 | 20.87% | 46.51% | 1.944M | 912.329K | 113.08% | -87.02% |
| Q2 2023 | -0.54 | -0.60 | 10.01% | 31.65% | 933K | 5.639M | -83.45% | -94.97% |
| Q1 2023 | -0.19 | -0.64 | 70.10% | 72.06% | 58.98M | 36.213M | 62.87% | 220.37% |
| Q4 2022 | -0.58 | -0.88 | 33.99% | 19.44% | 44.36M | 17.058M | 160.05% | 159.87% |
| Q3 2022 | -0.86 | -0.91 | 5.60% | -91.11% | 14.98M | 15.939M | -6.02% | 5.27% |
| Q2 2022 | -0.79 | -0.84 | 6.26% | -36.21% | 18.55M | 13.14M | 41.17% | 38.33% |
| Q1 2022 | -0.68 | -0.78 | 12.89% | -41.67% | 18.41M | 9.585M | 92.07% | 65.26% |
| Q4 2021 | -0.72 | -0.68 | -5.88% | -18.03% | 17.07M | 10.945M | 55.96% | 7.36% |
| Q3 2021 | -0.45 | -0.59 | 24.12% | 33.82% | 14.23M | 8.047M | 76.84% | 88.23% |
| Q2 2021 | -0.58 | -0.54 | -7.83% | -65.71% | 13.41M | 6.433M | 108.46% | 145.16% |
| Q1 2021 | -0.48 | -0.44 | -8.70% | -9.09% | 11.14M | 6.02M | 85.05% | 342.06% |
| Q4 2020 | -0.61 | -0.40 | -52.15% | - | 15.9M | 4.973M | 219.73% | - |
| Q3 2020 | -0.68 | -0.37 | -83.79% | - | 7.56M | 7.111M | 6.31% | - |
| Q2 2020 | -0.35 | -0.28 | -27.09% | - | 5.47M | 13.495M | -59.47% | - |
| Q1 2020 | -0.44 | -0.40 | -10.86% | - | 2.52M | 1.826M | 38.01% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
11.49%
Max EPS beat (4)
18.09%
Min EPS beat (4)
1.85%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
34.46%
Max Revenue beat (4)
84.97%
Min Revenue beat (4)
1.86%
Analysis
In the last 4 quarters, FATE has consistently beaten EPS estimates in all releases
FATE has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, FATE has beaten the EPS estimates by 11.5% on average.
In the last 4 quarters, FATE has beaten the revenue estimates by 34.5% on average.
Related analysis
FATE THERAPEUTICS INC / FATE Earnings FAQ
Can you provide information on whether FATE THERAPEUTICS INC beat earnings estimates in the last quarter?
FATE THERAPEUTICS INC (FATE) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does FATE THERAPEUTICS INC (FATE) beat earnings estimates?
In the last 4 quarters, FATE THERAPEUTICS INC (FATE) has beaten EPS estimates in 4 out of 4 releases.